Share Prices & Company Research

Market News

18 Aug 2025 | 18:23

Europe close: Shares mixed as Trump-Zelenskyy talks start in US

(Sharecast News) - European shares closed mixed on Monday as US President Donald Trump met Ukraine leader Volodymyr Zelenskyy in Washington for talks on an end to the war with Russia.

The pan-regional Stoxx 600 index finished 0.08% higher at 554. Germany's DAX was down 0.23% and France's CAC 40 fell 0.5%, while the UK's FTSE 100 recovered to be 0.21% higher.

Sentiment was hit when Trump, who has largely aligned the US with Russia, said overnight that Zelenskyy could end the war with Russia "almost immediately, if he wants to, or he can continue to fight".

He also ruled out Ukraine joining Nato or regain Crimea - a key demand from Moscow. The meeting follows Trump's short summit with Russian leader Vladimir Putin in Alaska on Friday, which ended without a ceasefire.

Zelenskyy will be joined by German Chancellor Friedrich Merz, French President Emmanuel Macron and UK Prime Minister Keir Starmer.

"The future of Ukraine hangs heavy in the balance as Zelenskyy, flanked by European leaders, prepares to meet Trump. Putin's high bar for a peace deal may scupper hopes for an end to the conflict, but with more details emerging about what land could be ceded or retained in Eastern Ukraine, there does seem be more substance to the talks," said Hargreaves Lansdown analyst Susannah Streeter.

There was a dearth or corporate news to drive trade in the middle of the August holiday period. Shares in UK food producer Cranswick were down after new allegations of cruelty towards piglets at another of its farms emerged on the weekend.

Vestas shares surged more than 16.4% to top the Stoxx after the US Treasury published guidelines for the qualification of wind and solar subsidies for projects to 2030. The news boosted other renewables shares, with EDP Renonvaveis, Orsted and RWE all higher.

Novo Nordisk jumped as the drugmaker's weight-loss drug Wegovy received an accelerated approval by the US Food and Drug Administration to treat a serious liver condition.

Reporting by Frank Prenesti for Sharecast.com

Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new portfolio or transferring your portfolio from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.